Dlase 300 Upgrade
510(k) K932065
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK932065 | Date22 Jul 1993 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- GEX
- Device Class
- Class II
- Regulation
- 21 CFR Part 878.4810
- Advisory Committee
- General, Plastic Surgery
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 26 Sep 2026
The Dlase 300 Upgrade is a medical device system designed for use in general and plastic surgery applications. It functions as an enhancement component for the Dlase 300 laser system.
This device is subject to FDA 510(k) clearance. It is identified under the product code GEX and was processed through a traditional clearance pathway.
Questions
AI-generated answers, 26 Sep 2026
What is the primary purpose of the Dlase 300 Upgrade?
The Dlase 300 Upgrade is specifically engineered to function as an enhancement component for the existing Dlase 300 laser system, supporting its use in general and plastic surgery applications.
What is the regulatory status of this device?
The Dlase 300 Upgrade has received FDA 510(k) clearance. It was processed through a traditional clearance pathway and determined to be substantially equivalent to existing devices under product code GEX.
Which medical specialties is this upgrade intended for?
This device is intended for use within the fields of general and plastic surgery, as indicated by the advisory committee classification associated with its regulatory filing.